biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The SMOKING Gun!!!

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Dec 16, 2022 7:01pm

111 Views

Post# 35177076

RE:RE:RE:RE:The SMOKING Gun!!!

Don't worry, jd. Biodexa wants to be a therapeutics company like Denali Therapeutics. It can develop its own therapeutics, including with world leading Q-Sphera through clinical trials. It doesn't want to simply be a seller of a component used in other company's therapeutics. BTI has also had trouble depending on licenses from others for delivery technology. Biodexa is going big!

JDavenport wrote: So, poof, if they're getting out of the platform delivery business, are they going to sell the Q-Shera and xB3 platforms separately or together?

Whaddaya tink?

Good deal for The DrDR Medicine Show.

jd